feed,title,long_url,short_url
Benzinga,Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-Î² Agonist ASC41,https://benzinga.com/pressreleases/21/02/n19764000/gannex-announces-positive-clinical-results-in-overweight-and-obese-subjects-for-its-thr-agonist-as,
